Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Authors
Keywords
miRNA-503, Drug resistance, Ovarian cancer, PI3K
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 297, Issue 3, Pages 699-707
Publisher
Springer Nature
Online
2018-01-11
DOI
10.1007/s00404-018-4649-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer
- (2016) Tomofumi Noguchi et al. ONCOLOGY
- miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E
- (2016) Xiaoyan Yang et al. ONCOLOGY REPORTS
- MicroRNA-503 represses epithelial–mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb
- (2016) Xinzhen Guo et al. TUMOR BIOLOGY
- Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
- (2015) Jane Borley et al. ANNALS OF MEDICINE
- miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer
- (2015) Anil Belur Nagaraj et al. Biomarkers in Medicine
- miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
- (2015) Priya Samuel et al. Expert Review of Anticancer Therapy
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
- (2015) Priya Samuel et al. TUMOR BIOLOGY
- Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
- (2014) Christian Rolfo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer
- (2014) Yi Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2
- (2013) TIANZHU QIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
- (2013) Zachary Dobbin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- microRNA involvement in human cancer
- (2012) M. V. Iorio et al. CARCINOGENESIS
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- MicroRNA-mediated drug resistance in breast cancer
- (2011) Kristy R. Kutanzi et al. Clinical Epigenetics
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Screening for Ovarian Cancer
- (2009) Daniel L. Clarke-Pearson NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now